Blockade of microglial adenosine A2A receptor impacts inflammatory mechanisms, reduces ARPE-19 cell dysfunction and prevents photoreceptor loss in vitro
Related Experiment Video
Updated: Feb 15, 2026

Magnetic Isolation of Microglial Cells from Neonate Mouse for Primary Cell Cultures
Published on: July 25, 2022
M H Madeira1,2,3, K Rashid3, A F Ambrósio1,2,4
1Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Abstract:
Age-related macular degeneration (AMD) is characterized by pathological changes in the retinal pigment epithelium (RPE) and loss of photoreceptors. Growing evidence has demonstrated that reactive microglial cells trigger RPE dysfunction and loss of photoreceptors, and inflammasome pathways and complement activation contribute to AMD pathogenesis. We and others have previously shown that adenosine A2A receptor (A2AR) blockade prevents microglia-mediated neuroinflammatory processes and mediates protection to the retina. However, it is still unknown whether blocking A2AR in microglia protects against the pathological features of AMD. Herein, we show that an A2AR antagonist, SCH58261, prevents the upregulation of the expression of pro-inflammatory mediators and the alterations in the complement system triggered by an inflammatory challenge in human microglial cells. Furthermore, blockade of A2AR in microglia decreases the inflammatory response, as well as complement and inflammasome activation, in ARPE-19 cells exposed to conditioned medium of activated microglia. Finally, we also show that blocking A2AR in human microglia increases the clearance of apoptotic photoreceptors. This study opens the possibility of using selective A2AR antagonists in therapy for AMD, by modulating the interplay between microglia, RPE and photoreceptors.
Insights
Blocking adenosine A2A receptors (A2A R) in microglia reduces inflammation and enhances photoreceptor clearance, offering a potential therapy for age-related macular degeneration (AMD). This approach targets key pathways involved in AMD pathogenesis.
Area of Science:
- Ophthalmology
- Neuroscience
- Immunology
Background:
- Age-related macular degeneration (AMD) involves retinal pigment epithelium (RPE) damage and photoreceptor loss.
- Microglia activation, inflammasome pathways, and complement system contribute to AMD pathogenesis.
- Adenosine A2A receptor (A2A R) blockade shows neuroprotective effects by inhibiting microglia-mediated inflammation.
Purpose of the Study:
- To investigate if blocking A2A R in microglia can prevent AMD-associated pathological features.
- To determine the effect of A2A R antagonism on microglial inflammatory responses and photoreceptor health.
Main Methods:
- Used an A2A R antagonist (SCH58261) on human microglial cells and ARPE-19 cells.
- Assessed inflammatory mediators, complement system, inflammasome activation, and photoreceptor clearance.
- Exposed ARPE-19 cells to conditioned medium from activated microglia.
Main Results:
- A2A R antagonist prevented upregulation of pro-inflammatory mediators and complement alterations in microglia.
- A2A R blockade reduced inflammation, complement, and inflammasome activation in RPE cells exposed to activated microglia.
- Blocking A2A R in microglia enhanced the clearance of apoptotic photoreceptors.
Conclusions:
- A2A R antagonism in microglia mitigates key inflammatory pathways implicated in AMD.
- Modulating the A2A R offers a potential therapeutic strategy for AMD by targeting microglia-RPE-photoreceptor interactions.
- Selective A2A R antagonists may be a viable treatment for AMD.
Related Concept Videos
Reducing Line Loss
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
Adaptations that Reduce Water Loss
Photoreceptors and Plant Responses to Light
Neuromuscular Junction And Blockade
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...

